Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $176.60 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $130.27 | 5 | $0 (2023) |
| Boston Scientific Corporation | $27.38 | 1 | $0 (2023) |
| Bioventus LLC | $18.95 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $51.68 | 2 | Boston Scientific Corporation ($27.38) |
| 2022 | $124.92 | 5 | Myriad Genetic Laboratories, Inc. ($105.97) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: rezum_URO | ||||||
| 11/15/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 08/31/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 07/22/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $24.92 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 06/21/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $24.92 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/08/2022 | Bioventus LLC | Exogen Ultrasound Bone Healing System (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,732 | 2,171 | $449,583 | $104,772 |
| 2022 | 33 | 2,424 | 3,056 | $757,622 | $175,281 |
| 2021 | 22 | 1,591 | 1,951 | $378,455 | $94,548 |
| 2020 | 23 | 1,060 | 1,240 | $282,709 | $58,360 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 389 | 495 | $93,060 | $33,323 | 35.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 67 | 75 | $66,750 | $15,112 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $32,548 | $9,934 | 30.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 66 | $27,258 | $8,904 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 68 | $18,632 | $6,194 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $12,604 | $3,903 | 31.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 13 | 14 | $19,600 | $3,851 | 19.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 16 | 63 | $26,775 | $3,216 | 12.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 126 | 149 | $11,324 | $2,667 | 23.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 17 | $46,250 | $2,429 | 5.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 24 | 24 | $34,632 | $2,359 | 6.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 47 | $5,452 | $2,051 | 37.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 182 | 229 | $3,435 | $1,924 | 56.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 165 | 199 | $22,885 | $1,739 | 7.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,368 | $1,480 | 33.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 78 | 86 | $3,010 | $712.94 | 23.7% |
| 87088 | Bacterial urine culture | Office | 2023 | 78 | 90 | $3,060 | $698.67 | 22.8% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 78 | 89 | $2,937 | $689.00 | 23.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 22 | $2,662 | $635.80 | 23.9% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 24 | 24 | $2,568 | $591.57 | 23.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 40 | $2,880 | $503.00 | 17.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 15 | 17 | $1,802 | $429.93 | 23.9% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 15 | 17 | $1,377 | $362.10 | 26.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 91 | 105 | $1,365 | $317.54 | 23.3% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 27 | 35 | $455.00 | $296.78 | 65.2% |
About Michael Lipsky
Michael Lipsky is a Urology healthcare provider based in Berkeley Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1245673110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Lipsky has received a total of $176.60 in payments from pharmaceutical and medical device companies, with $51.68 received in 2023. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($176.60).
As a Medicare-enrolled provider, Lipsky has provided services to 6,807 Medicare beneficiaries, totaling 8,418 services with total Medicare billing of $432,961. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Berkeley Heights, NJ
- Active Since 04/10/2013
- Last Updated 07/10/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1245673110
Products in Payments
- Prolaris (Device) $105.97
- Rezum Generator (Device) $27.38
- PROLARIS (Device) $24.30
- Exogen Ultrasound Bone Healing System (Device) $18.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.